A Dose-Ranging Study of the Effect of Glycopyrrolate in Subjects With Axillary Hyperhidrosis

NCT02016885 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

198

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperhidrosis

Interventions

DRUG: glycopyrrolate, 1.0%
DRUG: glycopyrrolate, 2.0%
DRUG: glycopyrrolate, 3.0%
DRUG: glycopyrrolate, 4.0%
OTHER: Vehicle

Sponsor

Journey Medical Corporation